Cargando...
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...
Gardado en:
| Publicado en: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099522/ https://ncbi.nlm.nih.gov/pubmed/34007411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9959320 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|